Carsten Denkert
Artificial Intelligence · 2010–2022
A researcher in the Science corpus: 16 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 6 citations into it
- Statistics and Probability — 5 citations into it
Whom Carsten Denkert trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Carsten Denkert overall
Papers from Carsten Denkert's perspective
Ordered by how strongly the researchers Carsten Denkert trusts endorse each paper. Same corpus, a different order for every researcher.
- Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. (Journal of Clinical Oncology)
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Archives of Pathology & Laboratory Medicine)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (Journal of the National Cancer Institute)
- The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel… (Journal of Clinical Oncology)
- Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. (Journal of Clinical Oncology)
- Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health… (Journal of Clinical Oncology)
- Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. (Journal of the National Cancer Institute)
- Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. (Journal of Clinical Oncology)
- A gene-expression signature as a predictor of survival in breast cancer. (New England Journal of Medicine)
Their papers
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients (2010) — 2,609 citations
- Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. (2022) — 879 citations
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021) — 687 citations
- Breast cancer (2021) — 631 citations
- Pembrolizumab for Early Triple-Negative Breast Cancer. (2020) — 2,341 citations
- Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group (2020) — 663 citations
- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. (2019) — 617 citations
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. (2018) — 1,800 citations
- Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. (2017) — 699 citations
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic (2016) — 830 citations
- Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. (2015) — 942 citations
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial. (2014) — 906 citations
- Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. (2012) — 2,412 citations
- Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach (2012) — 247 citations
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization (2012) — 1,152 citations
- Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. (2010) — 1,620 citations